Editorial
Acesso aberto
Revisado por pares
Objective Response by mRECIST Is an Independent Prognostic Factor of Overall Survival in Systemic Therapy for Hepatocellular Carcinoma
2019; Karger Publishers; Volume: 8; Issue: 2 Linguagem: Inglês
10.1159/000497460
ISSN2235-1795
Autores Tópico(s)Hepatitis B Virus Studies
Referência(s)